Cargando…
Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)
Multiple sclerosis is a complex, autoimmune-mediated disease of the central nervous system characterized by inflammatory demyelination and axonal/neuronal damage. The approval of various disease-modifying therapies and our increased understanding of disease mechanisms and evolution in recent years h...
Ejemplares similares
-
Multiple Sklerose Therapie Konsensus Gruppe (MSTKG): Positionspapier zur verlaufsmodifizierenden Therapie der Multiplen Sklerose 2021 (White Paper)
por: Wiendl, Heinz, et al.
Publicado: (2021) -
Multiple sclerosis therapy consensus group (MSTCG): answers to the discussion questions
por: Wiendl, Heinz, et al.
Publicado: (2021) -
Disseminated necrotizing leukoencephalopathy eight months after alemtuzumab treatment for multiple sclerosis
por: Metz, Imke, et al.
Publicado: (2016) -
Multiple sclerosis and nutrition: back to the future?
por: Gold, Ralf, et al.
Publicado: (2020) -
The Use of Digital and Remote Communication Technologies as a Tool for Multiple Sclerosis Management: Narrative Review
por: Marziniak, Martin, et al.
Publicado: (2018)